NCT04856098View on ClinicalTrials.gov

Absorption of Indacaterol and Glycopyrronium From Ultibro Breezhaler

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

May 7, 2021

Primary Completion Date

September 21, 2021

Study Completion Date

September 21, 2021

Conditions
Healthy Volunteers
Interventions
DRUG

Indacaterol maleate and glycopyrronium bromide

Batch A Ultibro Breezhaler 85/43 μg 2 capsules

DRUG

Indacaterol maleate and glycopyrronium bromide

Batch A Ultibro Breezhaler 85/43 μg 1 capsule

DRUG

Indacaterol maleate and glycopyrronium bromide

Batch B Ultibro Breezhaler 85/43 μg 2 capsules

DRUG

Ultibro Breezhaler with oral charcoal

Activated charcoal suspension, granules 50 g / bottle

Trial Locations (1)

Unknown

CRST Helsinki Oy, Helsinki

All Listed Sponsors
lead

Orion Corporation, Orion Pharma

INDUSTRY